Fibroblast Growth Factor 21 (FGF21) Protects against High Fat Diet Induced Inflammation and Islet Hyperplasia in Pancreas

Fibroblast growth factor 21 (FGF21) is an important endocrine metabolic regulator expressed in multiple tissues including liver and adipose tissue. Although highest levels of expression are in pancreas, little is known about the function of FGF21 in this tissue. In order to understand the physiology of FGF21 in the pancreas, we analyzed its expression and regulation in both acinar and islet tissues. We found that acinar tissue express 20-fold higher levels than that observed in islets. We also observed that pancreatic FGF21 is nutritionally regulated; a marked reduction in FGF21 expression was noted with fasting while obesity is associated with 3–4 fold higher expression. Acinar and islet cells are targets of FGF21, which when systemically administered, leads to phosphorylation of the downstream target ERK 1/2 in about half of acinar cells and a small subset of islet cells. Chronic, systemic FGF21 infusion down-regulates its own expression in the pancreas. Mice lacking FGF21 develop significant islet hyperplasia and periductal lymphocytic inflammation when fed with a high fat obesogenic diet. Inflammatory infiltrates consist of TCRb+ Thy1+ T lymphocytes with increased levels of Foxp3+ regulatory T cells. Increased levels of inflammatory cells were coupled with elevated expression of cytokines such as TNFα, IFNγ and IL1β. We conclude that FGF21 acts to limit islet hyperplasia and may also prevent pancreatic inflammation.

[1]  Yuan Zhang,et al.  Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. , 2015, Biochimica et biophysica acta.

[2]  F. Villarroya,et al.  Fibroblast growth factor 21 protects the heart from oxidative stress. , 2015, Cardiovascular research.

[3]  Xiaokun Li,et al.  FGF21 deletion exacerbates diabetic cardiomyopathy by aggravating cardiac lipid accumulation , 2015, Journal of cellular and molecular medicine.

[4]  W. So,et al.  Loss of fibroblast growth factor 21 action induces insulin resistance, pancreatic islet hyperplasia and dysfunction in mice , 2015, Cell Death and Disease.

[5]  S. Kliewer,et al.  Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding , 2014, Diabetes.

[6]  D. Schuppan,et al.  Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets. , 2014, Gastroenterology.

[7]  D. Moller,et al.  FGF21-based pharmacotherapy – potential utility for metabolic disorders , 2014, Trends in Endocrinology & Metabolism.

[8]  R. Mehmood,et al.  Silencing of the Fibroblast growth factor 21 gene is an underlying cause of acinar cell injury in mice lacking MIST1. , 2014, American journal of physiology. Endocrinology and metabolism.

[9]  J. Gaglia,et al.  Soluble Factors Secreted by T Cells Promote β-Cell Proliferation , 2013, Diabetes.

[10]  J. Hald,et al.  Fibroblast Growth Factor 21 (FGF21) and Glucagon-Like Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor–Deficient Mice , 2013, Diabetes.

[11]  A. Xu,et al.  High Glucose Represses β-Klotho Expression and Impairs Fibroblast Growth Factor 21 Action in Mouse Pancreatic Islets , 2013, Diabetes.

[12]  Gang Li,et al.  High-Fat, High-Calorie Diet Promotes Early Pancreatic Neoplasia in the Conditional KrasG12D Mouse Model , 2013, Cancer Prevention Research.

[13]  G. Shulman,et al.  Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice. , 2013, Endocrinology.

[14]  J. Kopchick,et al.  The GH/IGF-1 axis in ageing and longevity , 2013, Nature Reviews Endocrinology.

[15]  A. Wagers,et al.  Liver-derived systemic factors drive β cell hyperplasia in insulin-resistant states. , 2013, Cell reports.

[16]  Nobuyuki Itoh,et al.  Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine , 2012, Nature Medicine.

[17]  A. Adams,et al.  FGF21: The center of a transcriptional nexus in metabolic regulation. , 2012, Current diabetes reviews.

[18]  B. Faircloth,et al.  Primer3—new capabilities and interfaces , 2012, Nucleic acids research.

[19]  B. Spiegelman,et al.  FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. , 2012, Genes & development.

[20]  F. Villarroya,et al.  Thermogenic Activation Induces FGF21 Expression and Release in Brown Adipose Tissue* , 2011, The Journal of Biological Chemistry.

[21]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[22]  J. Flier,et al.  Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State , 2010, Diabetes.

[23]  S. Uemoto,et al.  FGF-21 enhances islet engraftment in mouse syngeneic islet transplantation model , 2010, Islets.

[24]  N. Chinookoswong,et al.  Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects. , 2009, American journal of physiology. Endocrinology and metabolism.

[25]  E. Fazio,et al.  Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. , 2009, Gastroenterology.

[26]  J. Flier,et al.  Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. , 2009, Endocrinology.

[27]  Junghyo Jo,et al.  Islet architecture: A comparative study , 2009, Islets.

[28]  Jason K. Kim,et al.  Fibroblast Growth Factor 21 Reverses Hepatic Steatosis, Increases Energy Expenditure, and Improves Insulin Sensitivity in Diet-Induced Obese Mice , 2009, Diabetes.

[29]  M. Eriksson,et al.  The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. , 2008, Cell metabolism.

[30]  P. Pfluger,et al.  Sirt1 protects against high-fat diet-induced metabolic damage , 2008, Proceedings of the National Academy of Sciences.

[31]  J. Flier,et al.  Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. , 2007, Cell metabolism.

[32]  S. Kliewer,et al.  Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. , 2007, Cell metabolism.

[33]  J. Gromada,et al.  Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways , 2006, Diabetes.

[34]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[35]  K. Wellen,et al.  Obesity-induced inflammatory changes in adipose tissue. , 2003, The Journal of clinical investigation.

[36]  C. Kahn,et al.  Evidence for a circulating islet cell growth factor in insulin-resistant states , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Hanahan,et al.  Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. , 1999, The Journal of clinical investigation.

[38]  C. Kahn,et al.  Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.

[39]  I. Campbell,et al.  Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice. , 1994, The American journal of pathology.

[40]  A. Papavassiliou,et al.  Brown Adipose Tissue Responds to Cold and Adrenergic Stimulation by Induction of FGF21 , 2011, Molecular medicine.

[41]  J. Gromada,et al.  Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways. , 2006, Diabetes.

[42]  M. Bouxsein,et al.  Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. , 2004, The Journal of clinical investigation.

[43]  V. Go.  The Pancreas : biology, pathobiology, and disease , 1993 .